Companies

Covidien has announced the start of enrollment in two clinical trials that it says further underscores the safety and effectiveness of the company’s advanced neurovascular solutions.

Newly presented study findings provide reassurance that performance of Abbott’s fully absorbable coronary stent is equivalent to its metallic forebeer at one year.

Medtronic has gained CE Mark approval for the 23 mm CoreValve® Evolut™ R TAVI System and has seen the device’s first implantation in its U.S. study.

Legal-Bay LLC, tells us that a Federal Jury in West Virginia has awarded a husband and wife $3.27 million in damages against Ethicon, Johnson & Johnson’s mesh product division in what is another loss for transvaginal mesh manufacturers

J&J’s Codman Neuro tells us it has entered into an exclusive distribution agreement with Pulsar Vascular to market and promote the PulseRider® wide neck aneurysm device in Europe, the Middle East and Africa.

A former S&N employee has ultimately scored pretty highly with life-changing winnings from whistleblowing on the illicit behaviour of his former employer.

J&J’s Codman Neuro has gained a clutch of Far Eastern regulatory approvals for its REVIVE™ SE Thrombectomy Device for restoring blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

Integra LifeSciences Holdings Corporation has announced that Mark Augusti has joined Integra as CVP, President, Orthopedics and Tissue Technologies in a role that will see him head up the company’s Spine and Extremities divisions.

Newly presented data says that using FFR measurement technology changed the course of treatment for more than one fifth of patients suffering non-ST segment elevation myocardial infarction (NSTEMI) heart attacks.

It’s good news/bad news for Boston Scientific’s Vagus Nerve Stimulation plans as a heart failure therapy. While efficacy endpoints suggested no outcome improvement, patients in the treatment group of the sham controlled study reported quality of life improvement.

St. Jude claims its Quadripolar pacing system set the standard and a newly presented study is a strong addition to the more than 100 publications supporting the argument.

Medtronic has gained U.S. FDA 510(k) clearance for its SHILLA™ Growth Guidance System, designed to treat spinal deformities in skeletally immature pediatric patients with severe, progressive, life-threatening, early-onset spinal deformities.

When a device is relied on to provide distraction, it’s obviously alarming when it has the potential to reverse direction. The consequences are significant enough to warrant the FDA classifying Depuy Synthes’ recall as Class I.

Ethicon is introducing three new endocutter and energy products at the 19th World Congress of International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO 2014).

Medtech Titan Medtronic has acquired Dutch Neuro device developer and its novel Deep Brain Stimulation system

CE marked earlier in the year, Medtronic’s Viva CRT-P system will now be available for US patients following its newly announced FDA approval.